Alan Dean
InvestorSenior Managing Partner at Targeted Technology Funds
About
Co-founder and senior managing partner of Targeted Technology Fund I with over 30 years in technology development. Previously Managing Partner of Fund Operations at Greer Capital Advisors and director of the technology ventures office at UTHSCSA; also co-founded technology spin-offs including Southern Bio Systems. Holds an MBA from UAB and a BS in Chemistry from the University of Alabama.
Deals · 24
DnatrixSolo GP
via Targeted Technology Funds · filed Sep 2018
Roxy'S RemediesSolo GP
via Targeted Technology Funds · filed Dec 2015
CytocentricsSolo GP
via Targeted Technology Funds · filed Mar 2015
Aerin MedicalSolo GP
BioDtech, Inc.Solo GP
BluegrassvascularSolo GP
CardiovateSolo GP
NeoSurgicalSolo GP
Smith+NephewSolo GP
StemBioSysSolo GP
VidacareSolo GP
XenexSolo GP
3DSolo GP
BiO2 Medical, Inc.Solo GP
Bio2MedicalSolo GP
Bluegrass Vascular Technologies, Inc.Solo GP
CytoBioscienceSolo GP
ENTrigue Surgical, Inc.Solo GP
Santalis Pharmaceuticals, Inc.Solo GP
Soluble Bioscience, LLCSolo GP
Soluble TherapeuticsSolo GP
ViroXis Corporation, Inc.Solo GP
Xenex Disinfection ServicesSolo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.